Navigation Links
Breakthrough optical technology to assess colon cancer risk, accuracy
Date:10/1/2008

Researchers at NorthShore University HealthSystem (NorthShore) and Northwestern University have discovered that fiber optic technology can for the very first time effectively measure blood levels in the colonic lining (mucosa) in humans, thus having potential applications for analyzing risk of colon cancer.

The study appears in the October 2008 issue of Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

The study used fiber optic technology to map microvascular blood content in patients during colonoscopy. The results provide the first indication that the early increase in blood supply (EIBS) is detectable in humans and that a high blood level mirrors proximity to neoplasia (process of tumor formation). The findings also suggest that this technology could be a valuable screening tool for enhancing polyp detection and could lead to improvements in colon cancer prevention.

"Our premise is that since the lining of the large intestine -- rectum and colon -- is contiguous, if you see an abnormality in one part of the colon, then somewhere else in the colon you have a higher likelihood of harboring an adenoma [benign tumor] or carcinoma [malignant tumor]," said Hemant K. Roy, M.D., director of gastroenterology research at NorthShore University HealthSystem and the study's principal clinical researcher. "EIBS strengthens our premise thanks largely to the unique and accurate ability of Four Dimensional Elastic Light Scattering Fingerprinting (4D-ELF)."

This state-of-the-art light probe was developed by Vadim Backman, professor of biomedical engineering at Northwestern University's McCormick School of Engineering and Applied Science. It utilizes a revolutionary light scattering technology that can detect subtle abnormal changes in cells lining the colon long before those changes can be seen under a microscope, and even before polyps form.

"It's fascinating," said Roy, "to very precisely know that you're looking at the most superficial layer of tissue -- which is where all polyps and cancer start -- and the accuracy with which these things can be measured."

Researchers used the optic probe to measure oxygenated (Ohb) and deoxygenated (Dhb) hemoglobin (Hb) specifically in the colonic lining where small blood vessels circulate. At NorthShore's Evanston Hospital, 222 patients undergoing colonoscopy screening were recruited for the study in 2006 and 2007.

Of these patients, 175 had no adenomas detected, 35 had non-advanced adenomas and 12 had advanced adenomas (polyps larger than one centimeter). The mean age was 56.6 years and 40 percent were female. There were no significant differences in gender. The groups did not significantly differ in tobacco or alcohol history.

The study found that the total Hb concentration was elevated 75.3 percent above control levels (comparable region from patients with no adenomas) at the adenoma site and persisted in the uninvolved mucosa (microscopically normal) area. Moreover, tissue sites located within 10 and 30 centimeters away from an adenoma also manifested a highly statistically significant increase in total Hb, OHb and DHb concentration.

"We are not determining whether an abnormality is cancer or not cancer," said Roy. "What we are doing is using optical technology to determine if we can assess risk through looking at field carcinogenesis [cancer formation]. The potential clinical applications include enhanced polyp detection during colonoscopy."

"While the technology is still in the clinical trial phase," notes Michael Goldberg, M.D., head of gastroenterology at NorthShore University HealthSystem, "it could be available to patients at NorthShore in five years."

Colon cancer is the second-leading cause of cancer death in the United States, killing 55,000 Americans each year. The disease is 90 percent preventable if pre-cancerous polyps are detected early and removed.

"This partnership with Dr. Backman at Northwestern University has the potential of bringing a suite of technologies that is not meant to replace colonoscopy," said Roy, "but rather to more precisely determine risk and thereby help to individualize recommendations on the timing of colonoscopy for colon cancer screening. This improved efficiency and accuracy may aid in cancer prevention efforts."


'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Related biology news :

1. Chips are down as Manchester makes protein scanning breakthrough
2. Iowa Corn Promotion Board, NJIT to license breakthrough, safe bio-plastic alternative
3. New fingerprint breakthrough by forensic scientists
4. Genetic breakthrough explains dangerously high blood glucose levels
5. Concentrating on different aspects of pain leads to breakthrough in migraine genetics
6. Stem cell breakthrough offers diabetes hope
7. Breakthrough in plant research
8. Telecom research leads to solar cell breakthrough
9. Rice scientists make breakthrough in single-molecule sensing
10. Scientists achieve major genetics breakthrough
11. Pharmaceutical breakthrough may make a range of drugs cheaper and more available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2020)... ... March 20, 2020 , ... ... human embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), through a proprietary ... treatment of neurological, autoimmune, and rare orphan diseases, today announced that the U.S. ...
(Date:3/13/2020)... (PRWEB) , ... March 13, 2020 , ... ... regarding the lifespan of stored cord blood performed by Dr. Hal Boxmeyer and ... of storage time for cryogenically preserved cells under proper conditions. Cryo-Cell International marks ...
(Date:3/11/2020)... ... 11, 2020 , ... USARAD Holdings Inc., the leading US ... healthcare VC firms introduces a first of its kind COVID-19 screening program. The ... caused over 4,000 fatalities to date. Over the years, USARAD through its SecondOpinions.com ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... TORONTO (PRWEB) , ... February 21, 2020 , ... Join ... – Southeast Region of Sequence, Inc. for an informative session ... , Design Flexibility: Key elements to incorporate into facility design to add manufacturing ...
(Date:2/13/2020)... ... , ... Arriello , a provider of market access, ... Safety™ as part of the company’s continued growth in pharmacovigilance operations. , ... information such as SUSARs and ICSRS, aggregate report production, signal management, and management ...
(Date:2/5/2020)... ... 05, 2020 , ... Rare Disease Day® , held the last day ... Rare Disorders (NORD), to raise awareness amongst the general public and decision-makers about rare ... “Behind The Mystery” rare disease series will be shining the light on ...
(Date:1/28/2020)... Pa. (PRWEB) , ... January 28, 2020 , ... ... of Better Salivary Assay Kits . The new Salivary Total Human ... research. “By measuring total immunoglobulin G in saliva, researchers can extend the accuracy ...
Breaking Biology Technology: